Amy J. Dilcher

Amy Dilcher is special counsel in the Corporate Practice Group in the firm's Washington D.C. office.

Areas of Practice

Amy’s practice focuses on transactional and regulatory matters, helping healthcare organizations achieve their strategic business initiatives while navigating complex regulatory issues and mitigating risks associated with healthcare regulations in the areas of strategic affiliations, mergers and acquisitions, hospital and physician transactions, managed care matters, and other contractual arrangements. She also advises on a wide range of operational, compliance, and regulatory issues.

Amy brings over 25 years of health industry experience with a clinical background as a medical oncology/hematology nurse and having served as the Chief Legal Officer for a private equity-backed network of urology physician practices, the General Counsel for a private equity-backed management services organization serving the largest network of interventional pain management physician practices, and the General Counsel for the largest healthcare provider in western Maryland. 

Her inhouse experience includes developing and evolving the maturity of the legal function within the corporate law department setting including:

• Aligning legal services with industry benchmarks
• Implementing and streamlining legal processes to enhance productivity, transparency and the business partner experience
• Reducing legal spend and turnaround times for high volume matters
• Improving collaboration and workflow management between legal departments and outside counsel

As a result of working within healthcare organizations for over two decades, Amy has gained an in-depth understanding of the business, clinical and operational aspects of healthcare service delivery along with its challenges, which allows her to serve clients by providing holistic guidance, creative counsel, and practical solutions.

Certifications

Levels 100 and 200, Legal Lean Sigma Certification, Lean Legal Sigma Institute, 2020

Basic Mediation Certification, Baltimore Mediation Center, 2020

Experience

• Represented Clayton, Dubilier & Rice (CD&R), a private investment firm, in connection with its strategic partnership with Elevance Health, Inc. (NYSE: ELV)

Articles

Healthcare Law Blog Posts

• "HHS & DOJ FY 2022 Enforcement Targeted Fraud in COVID-19, Telemedicine, Opioid and Prescription Drugs, and Substance Use Treatment Centers, Among Other Initiatives," December 1, 2023
• "Fifth Circuit Rules to Reinstate Abortion Pill Restrictions," August 17, 2023

• "Access to Abortion Pill on the Precipice: A Deep Dive into the Federal Court Rulings that will Decide the Fate of Mifepristone," June 15, 2023

• "EMTALA and Pregnancy Care Remains a Federal Enforcement Priority," May 17, 2023

• "OIG 2022 Advisory Opinions: Year in Review," May 8, 2023
• "Access to Abortion Pill in Limbo: Navigating the Intricacies of Conflicting Federal Court Rulings in Texas and Washington State," April 14, 2023

• "Tracking the Waivers: Implications of the Wind Down of the COVID-19 Public Health Emergency," March 14, 2023

• "CMS’s Administrative Simplification Rule Aims to Increase Efficiency and Standardization for Health Care Attachments," March 7, 2023
• "CMS Streamlines Stark Law Self-Referral Disclosure Protocol (SRDP)," March 2, 2023

• "ICYMI: HIPAA and Social Media IRL," February 8, 2023

• "Finding Our Way Out of the Pandemic Haze: What Telehealth Tools Are Medicare Providers Allowed to Keep, and Which Must They Leave Behind?," November 30, 2022
• "Part 2: An Update on the Federal and State E-Roe-sion or P-Roe-tection of Abortion Rights," November 16, 2022
• "An Update on the Federal and State E-Roe-sion or P-Roe-tection of Abortion Rights," October 12, 2022
• "The FemTech Revolution," October 11, 2022 

• "EMTALA in the Post-Dobbs World," September 13, 2022
• "OIG Issues Favorable Advisory Opinion For Federally Qualified Health Center’s Smartphone Loan Program," August 11, 2022
• "New Population-Based Option for the Maryland Primary Care Program in 2023," July 8, 2022
• "7 Things to Know About the New AdvaMed Code Updates," April 13, 2022

Events

Digital Media